Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Novo Nordisk pulls Tresiba in Germany after pricing row

July 6, 2015 Manufacturing and Production, Sales and Marketing Drug pricing, Germany, Novo Nordisk, Reimbursement, Tresiba, market access

Novo Nordisk has discontinued its distribution of once-daily basal insulin Tresiba after pricing talks with the German body that represents …
News

Working Life: Bayer UK & Ireland’s chief executive Alexander Moscho

July 6, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Alexander Moscho, Bayer

How did you find your way into your current role?I think it started when I was young and I was …
Feature

Adam Zaeske appointed as managing director of Takeda UK and Ireland

July 6, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adam Zaeske, Takeda

Japanese pharma firm Takeda has appointed Adam Zaeske as managing director of Takeda UK and Ireland.Zaeske has been with Takeda …
Appointment

NHS England approves AbbVie’s Duodopa for Parkinson’s disease

July 6, 2015 Sales and Marketing AbbVie, Duodopa, James Palmer, NHS England, PPRS, Parkinson's, Parkinson's disease, commissioning

AbbVie has been handed a boost by NHS England, who has approved the prescribing of its Parkinson’s disease treatment Duodopa …
News

Vertex’s cystic fibrosis drug gets FDA approval

July 3, 2015 Research and Development, Sales and Marketing FDA, Orkambi, Vertex, cystic fibrosis, gene therapy

Vertex Pharmaceuticals cystic-fibrosis drug Orkambi, which could treat as many as 8,500 patients in the US, has been approved by …
News

Sanofi’s Toujeo approved in Japan

July 3, 2015 Manufacturing and Production, Sales and Marketing Japan, Lantus Lantus XR, Sanofi, diabetes, toujeo, type diabetes

The Ministry of Health, Labor and Welfare in Japan has given Sanofi a marketing authorisation for the diabetes drug the …
News

Astellas in ‘unacceptable’ Xtandi ABPI code breach

July 3, 2015 Medical Communications, Sales and Marketing ABPI Code, Astella, PMCPA, Xtandi

The industry code of conduct regulator has singled out Astellas for ‘particular censure’ for arranging a meeting for UK healthcare …
News

Prices to be printed on all prescribed NHS drugs over £20

July 2, 2015 Manufacturing and Production, Medical Communications, Sales and Marketing Jeremy Hunt, NHS, UK, drugs, health secretary, medicines

NHS drugs costing more than £20 will, from next year, have the price and the words “funded by the UK …
News

Boehringer Ingelheim launches Spiolto for COPD

July 2, 2015 Sales and Marketing Boehringer Ingelheim, COPD, Europe, Spiolto, Spiriva, Striverdi

Boehringer Ingelheim is beginning a new push in lung disease across Europe after being approved by regulators in nine countries …
News

Opdivo launched in the UK for skin cancer

July 2, 2015 Sales and Marketing BMS, Bristol-Myers Squibb, EMA, Early Access to Medicines Scheme, MHRA, eams, melanoma, opdivo, skin cancer

Bristol-Myers Squibb has launched its cancer immunotherapy treatment Opdivo in the UK for patients with advanced skin cancer. Opdivo (nivolumab) …
News

FDA sued over failure to disclose Sovaldi data

June 30, 2015 Sales and Marketing FDA, Gilead, hepatitis C, sofosbuvir, sovaldi

Two groups that campaign for wider access to medicines have filed a lawsuit against the FDA, in a bid to …
News

Celgene enters 10-year $1 billion pact with Juno

June 30, 2015 Research and Development, Sales and Marketing CAR-T, Celgene, Chimeric Antigen Receptor Technology, Juno, T Cell Receptor, TCR, brett wells

Celgene has invested $1 billion into Juno Therapeutics as part of a 10-year partnership aiming to study cures for cancer …
News

BMS’ Opdivo accepted to UK early access scheme

June 30, 2015 Sales and Marketing BMS, Cancer, NSCLC, eams, keytruda, opdivo

Bristol-Myers Squibb has scored another first with its new-generation oncology therapy Opdivo, which has become the first lung cancer drug …
News

The Partners hires creative director from InVentive

June 30, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Novo Nordisk, The International Aids Society, The partners, inventive, peter henshaw

Brand consultancy The Partners has appointed creative director Peter Henshaw to lead its creative offerings for the agency’s health team.  …
Appointment

Lilly and Immunocore collaborate on melanoma

June 29, 2015 Research and Development, Sales and Marketing LY2157299, LY2801653, brett wells, immunocore, lilly

Eli Lilly is teaming up again with UK biotech Immunocore in order to work together on immunotherapy-based clinical trials. Specifically …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026